Ares Commercial Real Estate
ACRE · NYSE
About ACRE
- Employees
- 4,250
- Headquarters
- New York City, New York
- Listed
- Apr 26, 2012
- Sector
- Financials
- Industry
- Mortgage Real Estate Investment Trusts (REITs)
- Website
- arescre.com
ACRE key statistics
- Market cap
- 182.53M
- Price-earnings ratio
- 0.00
- Dividend yield
- 18.17%
- Average volume
- 694.68K
- Volume
- 875.14K
- Open price
- $3.33
- High today
- $3.45
- Low today
- $3.29
- 52 Week high
- $5.89
- 52 Week low
- $3.28
Ares Commercial Real Estate (ACRE) at a glance
Ares Commercial Real Estate (ACRE) last traded at $3.29, with a market cap of 182.53M, a price-to-earnings ratio of 0.00 and a dividend yield of 18.17%.
Today the stock has traded between $3.29 and $3.45. The current price is 0.2% above the day's low and 4.6% below its high.
Volume so far is 875.14K shares, above the average of 694.68K shares a day.
Over the past year Ares Commercial Real Estate has ranged from $3.28 to $5.89, and now sits 1% of the way up that range.
Ares Commercial Real Estate met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.08 per share against an estimate of $0.0544.
The average analyst price target is $5.36, 62.8% above the current price, from 6 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy16.7%
- Hold66.7%
- Sell16.7%
- Low
- $5.05
- Now
- $3.29
- High
- $5.78
ACRE earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 101.4% on average.
- Q3 FY24: reported -$0.11 per share against an estimate of $0.0452
- Q4 FY24: reported -$0.20 per share against an estimate of $0.0117
- Q1 FY25: reported $0.17 per share against an estimate of $0.00
- Q2 FY25: reported -$0.20 per share against an estimate of $0.0428
- Q3 FY25: reported $0.08 per share against an estimate of $0.0224
- Q4 FY25: reported -$0.07 per share against an estimate of $0.0073
- Q1 FY26: reported -$0.17 per share against an estimate of $0.051
- Q2 FY26: reported $0.08 per share against an estimate of $0.0544
ACRE news
- Press releasePRNewswire
- Press releasePRNewswire
Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the Second Quarter Ended June 30, 2026
- Press releaseBusiness Wire
Ares Commercial Real Estate Corporation Reports First Quarter 2026 Results
- Press releaseBusiness Wire
Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2026
- Tim Melvin
7 Stocks Leading the Real Estate Recovery
- Avi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks With Over 12% Dividend Yields
- Press releaseBusiness Wire
Ares Commercial Real Estate Corporation Reports Fourth Quarter and Full Year 2025 Results
- Press releaseBusiness Wire
Ares Commercial Real Estate Corporation Announces Tax Reporting Information for Calendar Year 2025
Similar companies
Companies in the same industry as Ares Commercial Real Estate
- RWTRedwood Trust$3.02+3.42%
- KREFKKR Real Estate Finance Trust$5.64−0.88%
- NREFNexPoint Real Estate Finance$15.50+2.31%
- REFIChicago Atlantic Real Estate Finance$9.08+3.53%
- RCReady Capital$1.18+1.72%
- MITTTPG Mortgage Investment Trust$5.32+1.72%
- AOMRAngel Oak Mortgage REIT$7.20+1.98%
- CMTGClaros Mortgage Trust$1.15+3.60%
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.